Organ-on-chip platforms poised to accelerate nanoparticle drug development

Organ-on-chip platforms are set to enhance the development and testing of nanoparticle-based drug delivery by better mimicking human physiology, potentially overcoming limitations of traditional experimental models.

This Wire brief sits within Fusion42's coverage of Medtech.